(Q45076700)

English

Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study

scientific article published in December 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

1 reference

based on heuristic

inferred from title

author name string

Arthur S Walters

1

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

William G Ondo

2

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Tilman Dreykluft

3

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Ron Grunstein

4

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Daniel Lee

5

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Kapil Sethi

6

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

TREAT RLS 2 (Therapy with Ropinirole: Efficacy And Tolerability in RLS 2) Study Group

7

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

language of work or name

0 references

publication date

1 December 2004

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Movement Disorders

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

1414-1423

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and Morbidity in Augsburg Elderly.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.20257

21 January 2018

Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.20257

21 January 2018

Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome

1 reference

https://api.crossref.org/works/10.1002%2FMDS.20257

21 January 2018

Treatment of restless legs syndrome and periodic movements during sleep with L-dopa: a double-blind, controlled study

1 reference

https://api.crossref.org/works/10.1002%2FMDS.20257

21 January 2018

A randomized controlled study of pergolide in patients with restless legs syndrome.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.20257

21 January 2018

Long-term effects of pergolide in the treatment of restless legs syndrome

1 reference

https://api.crossref.org/works/10.1002%2FMDS.20257

21 January 2018

Randomized, double-blind, placebo-controlled trial of pergolide in restless legs syndrome.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.20257

21 January 2018

Restless legs syndrome improved by pramipexole: a double-blind randomized trial.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.20257

21 January 2018

Identifiers

10.1002/MDS.20257

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45076700&oldid=2065273174"